Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

HCSGHEALTHCARE SERVICES GROUP INC

Nasdaq · CIK 0000731012
Filer categoryLarge accelerated filer
Entity typeoperating
SIC8050 Services-Nursing & Personal Care Facilities
FY end1231
XBRL facts460

Identity from submissions API

NameHEALTHCARE SERVICES GROUP INC
CIK0000731012
TickersHCSG
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC8050 Services-Nursing & Personal Care Facilities
EIN232018365
LEI—
Fiscal year end1231
State of incorporationPA PA
Phone2159381661
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
3220 TILLMAN DRIVE
SUITE 300
BENSALEM
PA
19020
PA
Mailing address
3220 TILLMAN DRIVE
SUITE 300
BENSALEM
PA
19020
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1341 filing rows loaded from submissions recent; extra archives: CIK0000731012-submissions-001.json (341 filings, 1994-01-21 to 2007-02-28).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-001069 005-35875 261506894 34 7464
2026-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001631 005-35875 261505979 34 7583
2026-10-27 4 FORM 4 0001594748-26-000007 5039
2026-10-26 144 xsl144X01/primary_doc.xml 0001950047-26-010401 000-12015 261486061 33 4867
2026-10-23 10-Q 10-Q 0000731012-26-000059 000-12015 261482174 34 12990087 1 1
2026-10-21 8-K 8-K 2.02,9.01 0000731012-26-000055 000-12015 261474146 34 286841 1 1
2026-10-07 8-K 8-K 1.01,7.01,9.01 0000731012-26-000052 000-12015 261447605 34 829464 1 1
2026-10-01 4 FORM 4 0001811683-26-000013 5690
2026-10-01 4 FORM 4 0001890359-26-000014 5808
2026-10-01 4 FORM 4 0002071308-26-000014 5696
2026-08-05 4 FORM 4 0001704092-26-000007 5226
2026-08-04 144 xsl144X01/primary_doc.xml 0001950047-26-007658 000-12015 261239626 33 6045
2026-07-24 S-8 S-8 0000731012-26-000048 333-297680 261201605 33 229241 1 1
2026-07-24 10-Q 10-Q 0000731012-26-000046 000-12015 261201496 34 12920269 1 1
2026-07-22 8-K 8-K 2.02,9.01 0000731012-26-000040 000-12015 261191658 34 283391 1 1
2026-07-02 4 FORM 4 0001849650-26-000010 5019
2026-07-02 4 FORM 4 0001811683-26-000010 5690
2026-07-02 4 FORM 4 0002071308-26-000011 5696
2026-07-02 4 FORM 4 0001890359-26-000011 5808
2026-05-29 4/A FORM 4/A 0002036666-26-000008 8612
2026-05-28 4 FORM 4 0002071308-26-000008 5695
2026-05-28 4 FORM 4 0002134551-26-000006 4742
2026-05-28 4 FORM 4 0001403593-26-000003 5417
2026-05-28 4 FORM 4 0001890359-26-000008 5360
2026-05-28 4 FORM 4 0001811683-26-000007 5369
2026-05-28 4 FORM 4 0001521829-26-000003 5379
2026-05-28 4 FORM 4 0001645229-26-000002 5379
2026-05-28 4 FORM 4 0001743044-26-000005 5379
2026-05-28 4 FORM 4 0002036666-26-000006 7666
2026-05-27 8-K 8-K 5.07,9.01 0000731012-26-000036 000-12015 261026336 34 165434 1 1
2026-05-27 3 FORM 3 0002134551-26-000003 341535
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919859-26-000009 005-35875 26985935 34 6929
2026-04-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000668 005-35875 26921172 34 7456
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000432 005-35875 26913767 34 7400
2026-04-24 10-Q 10-Q 0000731012-26-000031 000-12015 26895772 34 10734793 1 1
2026-04-22 8-K 8-K 2.02,9.01 0000731012-26-000025 000-12015 26881274 34 259452 1 1
2026-04-15 DEF 14A DEF 14A 0000731012-26-000021 000-12015 26864821 34 20560519 1 1
2026-04-15 ARS ARS 0000731012-26-000019 000-12015 26864759 34 1531811
2026-04-13 8-K 8-K 1.01,2.03,9.01 0000731012-26-000015 000-12015 26858627 34 1265596 1 1
2026-04-02 4 FORM 4 0001890359-26-000005 5807
2026-04-02 4 FORM 4 0002071308-26-000005 5693
2026-04-02 4 FORM 4 0001811683-26-000004 5689
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001480 005-35875 26801533 34 7222
2026-02-26 144 xsl144X01/primary_doc.xml 0001950047-26-001858 000-12015 26691073 33 7062
2026-02-26 4 FORM 4 0001849650-26-000006 6037
2026-02-26 4 FORM 4 0001704092-26-000004 11570
2026-02-26 4 FORM 4 0001835033-26-000009 11545
2026-02-26 4 FORM 4 0001454244-26-000006 11546
2026-02-26 4 FORM 4 0001502211-26-000006 11564
2026-02-26 4 FORM 4 0001594748-26-000004 11550
2026-02-20 4 FORM 4 0001835033-26-000007 5910
2026-02-19 4 FORM 4 0001835033-26-000005 18787
2026-02-19 4 FORM 4 0001502211-26-000004 13053
2026-02-19 4 FORM 4 0001454244-26-000004 6367
2026-02-18 144 xsl144X01/primary_doc.xml 0001950047-26-001452 000-12015 26648990 33 6795
2026-02-18 144 xsl144X01/primary_doc.xml 0001950047-26-001450 000-12015 26648903 33 13514
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919859-26-000005 005-35875 26634925 34 7126
2026-02-13 10-K 10-K 0000731012-26-000009 000-12015 26633400 34 14410845 1 1
2026-02-11 8-K 8-K 2.02,9.01 0000731012-26-000004 000-12015 26618330 34 805645 1 1
2026-01-06 4 FORM 4 0001502211-26-000002 24958
2026-01-06 4 FORM 4 0001835033-26-000003 24943
2026-01-06 4 FORM 4 0001454244-26-000002 25113
2026-01-06 4 FORM 4 0001594748-26-000002 23377
2026-01-06 4 FORM 4 0001704092-26-000002 23346
2026-01-06 4 FORM 4 0002036666-26-000003 10347
2026-01-06 4 FORM 4 0001849650-26-000004 15728
2026-01-05 4 FORM 4 0001890359-26-000002 5540
2026-01-05 4 FORM 4 0002071308-26-000002 5561
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919859-25-000038 005-35875 251477957 34 7127
2025-10-29 4 FORM 4 0001594748-25-000004 4902
2025-10-29 4 FORM 4 0001704092-25-000003 5009
2025-10-28 144 xsl144X01/primary_doc.xml 0001950047-25-008238 000-12015 251426046 33 4856
2025-10-27 144 xsl144X01/primary_doc.xml 0001950047-25-008214 000-12015 251420729 33 5461
2025-10-24 10-Q 10-Q 0000731012-25-000108 000-12015 251416157 34 11970757 1 1
2025-10-22 8-K 8-K 2.02,9.01 0000731012-25-000104 000-12015 251408581 34 293283 1 1
2025-10-02 4 FORM 4 0001890359-25-000007 5541
2025-10-02 4 FORM 4 0002071308-25-000007 5562
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919859-25-000022 005-35875 251219557 34 7126
2025-07-30 4 FORM 4 0001502211-25-000005 4973
2025-07-28 144 xsl144X01/primary_doc.xml 0001950047-25-005231 000-12015 251156473 33 8348
2025-07-25 10-Q 10-Q 0000731012-25-000100 000-12015 251151672 34 11852413 1 1
2025-07-23 8-K 8-K 2.02,9.01 0000731012-25-000097 000-12015 251141608 34 289010 1 1
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000906304-25-000121 005-35875 251126315 34 10335
2025-07-10 8-K 8-K 7.01 0000731012-25-000094 000-12015 251116014 34 187122 1 1
2025-07-02 4 FORM 4 0001890359-25-000004 5680
2025-07-02 4 FORM 4 0002071308-25-000004 5246
2025-06-04 4 FORM 4 0000731012-25-000089 5247
2025-06-04 3 FORM 3 0000731012-25-000086 9305
2025-05-29 4 FORM 4 0000731012-25-000084 5242
2025-05-29 4 FORM 4 0000731012-25-000082 5448
2025-05-29 4 FORM 4 0000731012-25-000080 5232
2025-05-29 4 FORM 4 0000731012-25-000078 5242
2025-05-29 4 FORM 4 0000731012-25-000076 5242
2025-05-29 4 FORM 4 0000731012-25-000074 5226
2025-05-29 4 FORM 4 0000731012-25-000072 5280
2025-05-29 4 FORM 4 0000731012-25-000070 5223
2025-05-28 8-K 8-K 5.07,9.01 0000731012-25-000068 000-12015 25995751 34 162486 1 1
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919859-25-000016 005-35875 25942221 34 7124
2025-04-28 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-001780 005-35875 25879093 34 11219
2025-04-25 10-Q 10-Q 0000731012-25-000066 000-12015 25873668 34 10309795 1 1
2025-04-23 8-K 8-K 2.02,9.01 0000731012-25-000062 000-12015 25859190 34 265045 1 1
2025-04-14 DEF 14A DEF 14A 0000731012-25-000058 000-12015 25836323 34 41511632 1 1
2025-04-14 ARS ARS 0000731012-25-000056 000-12015 25836249 34 1513218
2025-04-01 4 FORM 4 0000731012-25-000052 5718
2025-04-01 4 FORM 4 0000731012-25-000050 5541
2025-02-26 4 FORM 4 0000731012-25-000048 6044
2025-02-26 4 FORM 4 0000731012-25-000046 11667
2025-02-26 4 FORM 4 0000731012-25-000044 11664
2025-02-26 4 FORM 4 0000731012-25-000042 11642
2025-02-26 4 FORM 4 0000731012-25-000040 11638
2025-02-26 4 FORM 4 0000731012-25-000038 11658
2025-02-19 4 FORM 4 0000731012-25-000036 6376
2025-02-14 10-K 10-K 0000731012-25-000032 000-12015 25628217 34 13538515 1 1
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919859-25-000005 005-35875 25621135 34 7139
2025-02-12 8-K 8-K 2.02,9.01 0000731012-25-000024 000-12015 25611921 34 815272 1 1
2025-01-06 4 FORM 4 0000731012-25-000020 27235
2025-01-06 4 FORM 4 0000731012-25-000018 25498
2025-01-06 4 FORM 4 0000731012-25-000016 25488
2025-01-06 4 FORM 4 0000731012-25-000014 25475
2025-01-06 4 FORM 4 0000731012-25-000012 27150
2025-01-06 4 FORM 4 0000731012-25-000010 7646
2025-01-06 4 FORM 4 0000731012-25-000008 19265
2025-01-02 4 FORM 4 0000731012-25-000006 5700
2025-01-02 4 FORM 4 0000731012-25-000004 5568
2025-01-02 4 FORM 4 0000731012-25-000002 5599
2024-11-13 SC 13G/A HEALTHCARE SERVICES GROUP, INC. AMENDMENT NO. SIX 0000919859-24-000039 005-35875 241455654 34 9280
2024-11-08 SC 13G/A us4219061086_110824.txt 0002012383-24-003395 005-35875 241439547 34 13868
2024-10-25 10-Q 10-Q 0000731012-24-000142 000-12015 241397057 34 10855473 1 1
2024-10-23 8-K 8-K 2.02,9.01 0000731012-24-000139 000-12015 241387799 34 296348 1 1
2024-10-18 SC 13G/A us4219061086_101824.txt 0002012383-24-000631 005-35875 241380607 34 13854
2024-10-16 8-K 8-K 8.01 0000731012-24-000134 000-12015 241375286 34 145618 1 1
2024-10-15 SC 13G/A hcsg2.txt 0000906304-24-000100 005-35875 241371053 34 11064
2024-10-02 4 FORM 4 0000731012-24-000129 5564
2024-10-02 4 FORM 4 0000731012-24-000127 5698
2024-10-02 4 FORM 4 0000731012-24-000125 5596
2024-09-11 3 FORM 3 0000731012-24-000123 9182
2024-09-09 8-K 8-K 5.02,7.01,9.01 0000731012-24-000118 000-12015 241287238 34 195238 1 1
2024-07-26 10-Q 10-Q 0000731012-24-000114 000-12015 241146886 34 12559557 1 1
2024-07-24 8-K 8-K 2.02,9.01 0000731012-24-000110 000-12015 241136089 34 392870 1 1
2024-07-19 UPLOAD filename1.pdf 0000000000-24-008204 000-12015 39848
2024-07-11 CORRESP filename1.htm 0000731012-24-000107 92649
2024-07-02 4 FORM 4 0000731012-24-000105 5568
2024-07-02 4 FORM 4 0000731012-24-000103 5599
2024-07-02 4 FORM 4 0000731012-24-000101 5700
2024-07-01 UPLOAD filename1.pdf 0000000000-24-007489 000-12015 43294
2024-06-20 CORRESP filename1.htm 0000731012-24-000099 91571
2024-06-06 UPLOAD filename1.pdf 0000000000-24-006519 000-12015 43994
2024-06-03 8-K 8-K 7.01,9.01 0000731012-24-000097 000-12015 241014993 34 191069 1 1
2024-05-29 4 FORM 4 0000731012-24-000094 5251
2024-05-29 4 FORM 4 0000731012-24-000092 5252
2024-05-29 4 FORM 4 0000731012-24-000090 5272
2024-05-29 4 FORM 4 0000731012-24-000088 5241
2024-05-29 4 FORM 4 0000731012-24-000086 5228
2024-05-29 4 FORM 4 0000731012-24-000084 5287
2024-05-29 4 FORM 4 0000731012-24-000082 5233
2024-05-29 4 FORM 4 0000731012-24-000080 5252
2024-05-29 8-K 8-K 5.07,9.01 0000731012-24-000078 000-12015 24999490 34 175399 1 1
2024-05-23 DEFA14A DEFA14A 0000731012-24-000075 000-12015 24975125 34 15264
2024-05-17 CORRESP filename1.htm 0000731012-24-000072 227228
2024-04-26 DEF 14A DEF 14A 0000731012-24-000067 000-12015 24884129 34 11550603 1 1
2024-04-26 10-Q 10-Q 0000731012-24-000065 000-12015 24883914 34 8956184 1 1
2024-04-26 ARS ARS 0000731012-24-000063 000-12015 24883492 34 950661
2024-04-24 8-K 8-K 2.02,9.01 0000731012-24-000059 000-12015 24866702 34 325871 1 1
2024-04-12 PRE 14A PRE 14A 0000731012-24-000056 000-12015 24842034 34 11567654 1 1
2024-04-10 UPLOAD filename1.pdf 0000000000-24-003866 000-12015 47707
2024-04-02 4 FORM 4 0000731012-24-000049 5598
2024-04-02 4 FORM 4 0000731012-24-000047 5566
2024-04-02 4 FORM 4 0000731012-24-000045 5698
2024-03-25 CORRESP filename1.htm 0000731012-24-000043 109588
2024-03-12 UPLOAD filename1.pdf 0000000000-24-002705 000-12015 47760
2024-02-29 4 FORM 4 0000731012-24-000041 4678
2024-02-27 4 FORM 4 0000731012-24-000039 4673
2024-02-27 4 FORM 4 0000731012-24-000037 8215
2024-02-27 4 FORM 4 0000731012-24-000035 8214
2024-02-27 4 FORM 4 0000731012-24-000033 8189
2024-02-27 4 FORM 4 0000731012-24-000031 8204
2024-02-27 4 FORM 4 0000731012-24-000029 8210
2024-02-22 4 FORM 4 0000731012-24-000027 6380
2024-02-16 10-K 10-K 0000731012-24-000025 000-12015 24648811 34 12917572 1 1
2024-02-14 8-K 8-K 2.02,9.01 0000731012-24-000019 000-12015 24632215 34 953626 1 1
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021094 005-35875 24628645 34 13121
2024-02-13 SC 13G/A healthcare.txt 0000919859-24-000007 005-35875 24625231 34 9216
2024-02-01 SC 13G/A SEC SCHEDULE 13G 0000914208-24-000039 005-35875 24586705 34 18271
2024-01-23 SC 13G hcsg.txt 0000906304-24-000018 005-35875 24551931 34 11050
2024-01-22 SC 13G/A Healthcare_Ser_Gr_Inc.txt 0000093751-24-000049 005-35875 24547573 34 8502
2024-01-19 SC 13G/A us4219061086_011924.txt 0001086364-24-000355 005-35875 24545173 34 13562
2024-01-08 4 FORM 4 0000731012-24-000016 27148
2024-01-08 4 FORM 4 0000731012-24-000014 27228
2024-01-08 4 FORM 4 0000731012-24-000012 25516
2024-01-08 4 FORM 4 0000731012-24-000010 22761
2024-01-08 4 FORM 4 0000731012-24-000008 25491
2024-01-08 4 FORM 4 0000731012-24-000006 25484
2024-01-02 4 FORM 4 0000731012-24-000004 5591
2024-01-02 4 FORM 4 0000731012-24-000002 5690
2023-10-27 10-Q 10-Q 0000731012-23-000119 000-12015 231355994 34 9184894 1 1
2023-10-25 8-K 8-K 2.02,9.01 0000731012-23-000115 000-12015 231343905 34 431014 1 1
2023-10-03 4 FORM 4 0000731012-23-000113 5585
2023-10-03 4 FORM 4 0000731012-23-000110 5486
2023-08-24 UPLOAD filename1.pdf 0000000000-23-009309 39694
2023-08-18 CORRESP filename1.htm 0000731012-23-000108 11844
2023-08-09 UPLOAD filename1.pdf 0000000000-23-008640 45515
2023-07-28 S-8 S-8 0000731012-23-000105 333-273517 231123602 33 105161
2023-07-28 10-Q 10-Q 0000731012-23-000103 000-12015 231123556 34 8715009 1 1
2023-07-26 8-K 8-K 2.02,9.01 0000731012-23-000098 000-12015 231110029 34 280782 1 1
2023-07-03 4 FORM 4 0000731012-23-000094 5499
2023-07-03 4 FORM 4 0000731012-23-000092 5598
2023-06-01 8-K 8-K 5.07,9.01 0000731012-23-000090 000-12015 23985787 34 399576 1 1
2023-05-31 4 FORM 4 0000731012-23-000088 5145
2023-05-31 4 FORM 4 0000731012-23-000086 5145
2023-05-31 4 FORM 4 0000731012-23-000084 5167
2023-05-31 4 FORM 4 0000731012-23-000082 5135
2023-05-31 4 FORM 4 0000731012-23-000080 5129
2023-05-31 4 FORM 4 0000731012-23-000077 5178
2023-05-31 4 FORM 4 0000731012-23-000075 5126
2023-05-31 4 FORM 4 0000731012-23-000073 5145
2023-05-01 DEFR14A DEF 14A REVISED 0000731012-23-000071 000-12015 23874733 34 3003064 1 1
2023-04-28 DEF 14A DEF 14A 0000731012-23-000067 000-12015 23867269 34 1709700
2023-04-28 10-Q 10-Q 0000731012-23-000065 000-12015 23867134 34 8518715 1 1
2023-04-28 ARS ARS 0000731012-23-000062 000-12015 23863666 34 646723
2023-04-26 8-K 8-K 2.02,9.01 0000731012-23-000047 000-12015 23846768 34 269012 1 1
2023-04-04 4 FORM 4 0000731012-23-000042 8818
2023-04-04 4 FORM 4 0000731012-23-000040 8985
2023-02-28 4 FORM 4 0000731012-23-000038 10841
2023-02-28 4 FORM 4 0000731012-23-000036 9320
2023-02-28 4 FORM 4 0000731012-23-000034 10855
2023-02-28 4 FORM 4 0000731012-23-000032 7591
2023-02-28 4 FORM 4 0000731012-23-000030 10870
2023-02-28 4 FORM 4 0000731012-23-000028 10848
2023-02-23 4 FORM 4 0000731012-23-000026 9560
2023-02-17 10-K 10-K 0000731012-23-000024 000-12015 23644172 34 12674624 1 1
2023-02-16 8-K 8-K 8.01 0000731012-23-000020 000-12015 23639496 34 272009 1 1
2023-02-15 8-K 8-K 2.02,8.01,9.01 0000731012-23-000016 000-12015 23633597 34 268534 1 1
2023-02-10 SC 13G SEC SCHEDULE 13G 0000914208-23-000216 005-35875 23607843 34 24039
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016105 005-35875 23603351 34 13016
2023-02-01 SC 13G Healthcare_Services_Grp_Inc.txt 0000093751-23-000081 005-35875 23575425 34 8554
2023-01-27 SC 13G/A ANNUAL 13G HEALTHCARE SERVICES GROUP INC. 0000919859-23-000005 005-35875 23561880 34 9155
2023-01-26 SC 13G/A us4219061086_012623.txt 0001306550-23-004136 005-35875 23554348 34 13308
2023-01-20 SC 13G/A us4219061086_012023.txt 0001306550-23-001168 005-35875 23540616 34 13280
2023-01-05 4 FORM 4 0000731012-23-000012 26154
2023-01-05 4 FORM 4 0000731012-23-000010 27851
2023-01-05 4 FORM 4 0000731012-23-000008 29424
2023-01-05 4 FORM 4 0000731012-23-000006 27834
2023-01-05 4 FORM 4 0000731012-23-000004 29585
2023-01-05 4 FORM 4 0000731012-23-000002 24287
2022-12-12 4 FORM 4 0000731012-22-000091 7854
2022-11-28 8-K 8-K 1.01,2.03,9.01 0000731012-22-000089 000-12015 221426484 34 2021778 1 1
2022-10-21 10-Q 10-Q 0000731012-22-000084 000-12015 221324298 34 9577444 1 1
2022-10-19 8-K 8-K 2.02,8.01,9.01 0000731012-22-000081 000-12015 221317218 34 270635 1 1
2022-07-22 10-Q 10-Q 0000731012-22-000073 000-12015 221100470 34 9223587 1 1
2022-07-20 8-K 8-K 2.02,7.01,9.01 0000731012-22-000070 000-12015 221094902 34 263336 1 1
2022-07-20 8-K 8-K 2.02,8.01,9.01 0000731012-22-000066 000-12015 221092741 34 271400 1 1
2022-06-17 8-K 8-K 8.01,9.01 0000731012-22-000063 000-12015 221024838 34 229763 1 1
2022-06-02 4 FORM 4 0000731012-22-000056 8478
2022-06-02 4 FORM 4 0000731012-22-000055 8468
2022-06-02 4 FORM 4 0000731012-22-000054 8492
2022-06-02 4 FORM 4 0000731012-22-000053 8468
2022-06-02 4 FORM 4 0000731012-22-000052 8454
2022-06-02 4 FORM 4 0000731012-22-000051 8496
2022-06-02 4 FORM 4 0000731012-22-000050 8477
2022-06-02 4 FORM 4 0000731012-22-000049 8481
2022-06-01 8-K 8-K 5.07,9.01 0000731012-22-000040 000-12015 22987892 34 191872 1 1
2022-04-22 DEF 14A DEF 14A 0000731012-22-000037 000-12015 22846716 34 1115662
2022-04-22 10-Q 10-Q 0000731012-22-000034 000-12015 22846396 34 8193060 1 1
2022-04-20 8-K 8-K 2.02,8.01,9.01 0000731012-22-000031 000-12015 22836316 34 251951 1 1
2022-02-23 4 FORM 4 0000731012-22-000028 9562
2022-02-18 10-K 10-K 0000731012-22-000026 000-12015 22653891 34 12495148 1 1
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-017719 005-35875 22609884 34 13012
2022-02-09 8-K 8-K 2.02,8.01,9.01 0000731012-22-000021 000-12015 22603784 34 271492 1 1
2022-02-07 SC 13G/A us4219061086_020722.txt 0000834237-22-007942 005-35875 22598109 34 13279
2022-02-04 SC 13G/A 13G ANNUAL - 0000919859-22-000012 005-35875 22592894 34 9128
2022-01-21 SC 13G/A HEALTHCARE SERVICES GROUP INC 13G AMENDMENT 0001112325-22-000004 005-35875 22545229 34 5888
2022-01-06 4/A FORM 4/A 0000731012-22-000018 30713
2022-01-05 4 FORM 4 0000731012-22-000016 32219
2022-01-05 4 FORM 4 0000731012-22-000015 30346
2022-01-05 4 FORM 4 0000731012-22-000014 33972
2022-01-05 4 FORM 4 0000731012-22-000013 33803
2022-01-05 4 FORM 4 0000731012-22-000012 33800
2022-01-05 4 FORM 4 0000731012-22-000011 22811
2022-01-05 4 FORM 4 0000731012-22-000010 8470
2022-01-05 4 FORM 4 0000731012-22-000009 9905
2021-11-24 4 FORM 4 0000731012-21-000080 11768
2021-11-10 3 FORM 3 0001890359-21-000003 6358
2021-10-22 10-Q 10-Q 0000731012-21-000078 000-12015 211341533 34 9586155 1 1
2021-10-20 8-K 8-K 2.02,5.02,8.01,9.01 0000731012-21-000073 000-12015 211332718 34 279433 1 1
2021-08-24 8-K 8-K 5.02,8.01,9.01 0000731012-21-000071 000-12015 211198914 34 184241 1 1
2021-07-23 10-Q 10-Q 0000731012-21-000068 000-12015 211111576 34 9415257 1 1
2021-07-21 8-K 8-K 2.02,8.01,9.01 0000731012-21-000064 000-12015 211102759 34 274184 1 1
2021-06-04 4 FORM 4 0000731012-21-000061 8396
2021-06-04 4 FORM 4 0000731012-21-000060 8533
2021-06-04 4 FORM 4 0000731012-21-000059 8564
2021-06-04 4 FORM 4 0000731012-21-000058 8369
2021-06-04 4 FORM 4 0000731012-21-000057 8383
2021-06-04 4 FORM 4 0000731012-21-000056 8392
2021-06-04 4 FORM 4 0000731012-21-000049 8542
2021-06-04 4 FORM 4 0000731012-21-000047 8393
2021-06-01 8-K 8-K 5.07,7.01,9.01 0000731012-21-000045 000-12015 21986155 34 195191 1 1
2021-05-24 DEFA14A FORM DEFA14A 0000731012-21-000042 000-12015 21955807 34 19918
2021-04-23 DEF 14A DEF 14A 0000731012-21-000040 000-12015 21850795 34 881007
2021-04-23 10-Q 10-Q 0000731012-21-000038 000-12015 21850610 34 8088326 1 1
2021-04-21 8-K 8-K 2.02,8.01,9.01 0000731012-21-000034 000-12015 21839560 34 260175 1 1
2021-04-12 SC 13G/A SCHEDULE 13G/A 0001104659-21-049162 005-35875 21819637 34 13873
2021-03-08 3 FORM 3 0000731012-21-000031 11722
2021-02-26 4 FORM 4 0000731012-21-000028 9551
2021-02-25 10-K 10-K 0000731012-21-000026 000-12015 21681785 34 11237349 1 1
2021-02-12 SC 13G/A 13G ANNUAL - HEALTHCARE SERVICES GROUP INC. 0000919859-21-000007 005-35875 21626631 34 9158
2021-02-11 SC 13G/A SC 13G/A 0001104659-21-020598 005-35875 21619019 34 60297
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-018251 005-35875 21610944 34 13884
2021-02-10 8-K 8-K 2.02,5.02,8.01,9.01 0000731012-21-000021 000-12015 21609261 34 286122 1 1
2021-02-08 SC 13G/A filing.txt 0000315066-21-001024 005-35875 21599562 34 8564
2021-02-05 4 FORM 4 0000731012-21-000018 10798
2021-02-04 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000252 005-35875 21589717 34 32862
2021-01-27 SC 13G/A us4219061086_012621.txt 0000834237-21-002011 005-35875 21555924 34 13412
2021-01-25 SC 13G HEALTHCARE SERVICES GROUP INC 13G 0001112325-21-000002 005-35875 21548902 34 5813
2021-01-06 4 FORM 4 0000731012-21-000016 28854
2021-01-06 4 FORM 4 0000731012-21-000015 30660
2021-01-06 4 FORM 4 0000731012-21-000014 30408
2021-01-06 4 FORM 4 0000731012-21-000013 25746
2021-01-06 4 FORM 4 0000731012-21-000012 28813
2021-01-06 4 FORM 4 0000731012-21-000011 25528
2021-01-04 3 FORM 3 0000731012-21-000004 20525
2020-12-04 4 FORM 4 0000731012-20-000089 13103
2020-12-04 4 FORM 4 0000731012-20-000088 11284
2020-12-04 4 FORM 4 0000731012-20-000087 11538
2020-11-27 4 FORM 4 0000731012-20-000085 10953
2020-11-16 4 FORM 4 0000731012-20-000083 11815
2020-11-12 8-K 8-K 5.02,8.01,9.01 0000731012-20-000081 000-12015 201303056 34 188734 1 1
2020-10-30 4 FORM 4 0000731012-20-000078 11407
2020-10-23 10-Q 10-Q 0000731012-20-000076 000-12015 201258469 34 10419231 1 1
2020-10-21 8-K 8-K 2.02,8.01,9.01 0000731012-20-000071 000-12015 201249602 34 311026 1 1
2020-10-02 SC 13G/A hcsg1020.txt 0000814133-20-000061 005-35875 201219014 34 3968
2020-07-24 S-8 S-8 0000731012-20-000069 333-240096 201047582 33 339806
2020-07-24 10-Q 10-Q 0000731012-20-000066 000-12015 201047504 34 10670102 1 1
2020-07-22 4 FORM 4 0000731012-20-000061 8519
2020-07-21 8-K 8-K 2.02,8.01,9.01 0000731012-20-000059 000-12015 201039508 34 355221 1 1
2020-06-05 8-K/A 8-K/A 5.07,7.01,8.01,9.01 0000731012-20-000056 000-12015 20947128 34 234599 1 1
2020-05-29 3 FORM 3 0000731012-20-000053 3041
2020-05-26 8-K 8-K 5.07,7.01,9.01 0000731012-20-000051 000-12015 20911881 34 227694 1 1
2020-04-24 DEF 14A DEF 14A 0000731012-20-000046 000-12015 20815926 34 2122373
2020-04-24 10-Q 10-Q 0000731012-20-000044 000-12015 20815886 34 9283302 1 1
2020-04-22 8-K 8-K 2.02,8.01,9.01 0000731012-20-000041 000-12015 20806138 34 298233 1 1
2020-02-26 4 FORM 4 0000731012-20-000035 11020
2020-02-21 10-K 10-K 0000731012-20-000033 000-12015 20641189 34 12359349 1 1
2020-02-14 SC 13G/A hcsg13gadec19.txt 0000080255-20-001061 005-35875 34 7038
2020-02-14 SC 13G/A 12/31/19 HEALTHCARE 0001274173-20-000069 005-35875 20616954 34 7700
2020-02-13 SC 13G/A HEALTHCARE SERVICES GROUP INC 0000919859-20-000015 005-35875 20610101 34 9144
2020-02-12 SC 13G/A SCHEDULE 13G/A 0001104659-20-017301 005-35875 20599183 34 13708
2020-02-12 8-K 8-K 2.02,5.02,8.01,9.01 0000731012-20-000029 000-12015 20598369 34 364546 1 1
2020-02-10 SC 13G hcsg220.txt 0000814133-20-000009 005-35875 20590867 34 4003
2020-02-10 SC 13G/A SC 13G/A 0001104659-20-013143 005-35875 20590481 34 56162
2020-02-07 SC 13G filing.txt 0000315066-20-001046 005-35875 20585734 34 8314
2020-02-04 SC 13G/A us4219061086_020320.txt 0000834237-20-002302 005-35875 20571981 34 13386
2020-01-28 SC 13G SEC SCHEDULE 13G 0000902219-20-000210 005-35875 20551722 34 37230
2020-01-06 4 FORM 4 0000731012-20-000026 32521
2020-01-06 4 FORM 4 0000731012-20-000025 26561
2020-01-06 4 FORM 4 0000731012-20-000024 26879
2020-01-06 4 FORM 4 0000731012-20-000023 21717
2020-01-06 4 FORM 4 0000731012-20-000022 25182
2020-01-06 4 FORM 4 0000731012-20-000021 8516
2020-01-06 4 FORM 4 0000731012-20-000020 8508
2020-01-06 4 FORM 4 0000731012-20-000019 8506
2020-01-06 4 FORM 4 0000731012-20-000018 8524
2020-01-06 4 FORM 4 0000731012-20-000017 8528
2020-01-06 4 FORM 4 0000731012-20-000016 8515
2020-01-06 4 FORM 4 0000731012-20-000015 8541
2020-01-06 4 FORM 4 0000731012-20-000014 8525
2019-12-05 4 FORM 4 0000731012-19-000076 11453
2019-11-22 4 FORM 4 0000731012-19-000074 16003
2019-10-25 S-8 S-8 0000731012-19-000072 333-234338 191170680 33 161178
2019-10-25 10-Q 10-Q 0000731012-19-000071 000-12015 191170641 34 8552253 1 1
2019-10-22 8-K 8-K 2.02,8.01,9.01 0000731012-19-000067 000-12015 191162226 34 347091 1 1
2019-09-13 4 FORM 4 0000731012-19-000065 7706
2019-07-26 10-Q 10-Q 0000731012-19-000063 000-12015 19978686 34 7697495 1 1
2019-07-23 8-K 8-K 2.02,5.02,8.01,9.01 0000731012-19-000061 000-12015 19968437 34 323902 1 1
2019-06-11 4 FORM 4 0000731012-19-000058 12628
2019-05-28 8-K 8-K 5.07 0000731012-19-000056 000-12015 19858531 34 57388
2019-05-03 10-Q 10-Q 0000731012-19-000053 000-12015 19797264 34 7064970 1 1
2019-04-30 8-K 8-K 2.02,8.01,9.01 0000731012-19-000050 000-12015 19783264 34 134183
2019-04-19 DEF 14A DEF 14A 0000731012-19-000048 000-12015 19758236 34 1534674
2019-03-22 4 FORM 4 0000731012-19-000042 10992
2019-03-18 10-K 10-K 0000731012-19-000040 000-12015 19688068 34 10879063 1 1
2019-03-04 8-K 8-K 8.01 0000731012-19-000037 000-12015 19652789 34 25047
2019-03-04 NT 10-K NT 10-K 0000731012-19-000036 000-12015 19652779 34 50266
2019-02-14 SC 13G hcsg13gdec18.txt 0000080255-19-002442 005-35875 34 6839
2019-02-13 SC 13G SC 13G 0001144204-19-007192 005-35875 19597566 34 55036
2019-02-12 SC 13G JANUS HENDERSON GROUP PLC OWNS 5.8% OF HCSG 0001274173-19-000097 005-35875 19590587 34 8198
2019-02-05 8-K FORM 8-K 2.02,8.01,9.01 0000731012-19-000031 000-12015 19568273 34 156608
2019-01-28 SC 13G/A us4219061086_012819.txt 0000215457-19-001542 005-35875 19545016 34 13359
2019-01-10 SC 13G/A healthcareservicesgroupinc.htm 0000932471-19-001334 005-35875 19520751 34 45165
2019-01-04 4 FORM 4 0000731012-19-000028 18409
2019-01-04 4 FORM 4 0000731012-19-000027 21666
2019-01-04 4 FORM 4 0000731012-19-000026 23261
2019-01-04 4 FORM 4 0000731012-19-000025 32588
2019-01-04 4 FORM 4 0000731012-19-000024 34177
2019-01-04 4 FORM 4 0000731012-19-000023 23379
2019-01-04 4 FORM 4 0000731012-19-000022 8515
2019-01-04 4 FORM 4 0000731012-19-000021 8506
2019-01-04 4 FORM 4 0000731012-19-000020 8528
2019-01-04 4 FORM 4 0000731012-19-000019 8524
2019-01-04 4 FORM 4 0000731012-19-000018 8525
2019-01-04 4 FORM 4 0000731012-19-000017 8508

Latest XBRL company facts

One latest value per concept from companyfacts (460 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 67.43M 2026-10-21 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
dei EntityPublicFloat Entity Public Float USD 897.00M 2025-06-30 2025 FY 10-K 2026-02-13 0000731012-26-000009
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 67.87M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0000731012-26-000021
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.67M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0000731012-26-000021
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.45M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0000731012-26-000021
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 155 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0000731012-26-000021
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 12.21M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0000731012-26-000021
ecd PeoTotalCompAmt PeoTotalCompAmt USD 4.73M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0000731012-26-000021
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 74 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0000731012-26-000021
ffd NetFeeAmt NetFeeAmt USD 7,854.44 2026-07-24 S-8 2026-07-24 0000731012-26-000048
ffd TtlFeeAmt TtlFeeAmt USD 7,854.44 2026-07-24 S-8 2026-07-24 0000731012-26-000048
ffd TtlOfferingAmt TtlOfferingAmt USD 56.88M 2026-07-24 S-8 2026-07-24 0000731012-26-000048
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-24 S-8 2026-07-24 0000731012-26-000048
srt StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased shares 7.50M 2023-02-14 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap AccountsAndFinancingReceivableAllowanceForCreditLoss Accounts and Financing Receivable, Allowance for Credit Loss USD 141.86M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AccountsAndNotesReceivableNet Accounts and Financing Receivable, after Allowance for Credit Loss USD 423.39M 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap AccountsNotesAndLoansReceivableNetCurrent Accounts and Financing Receivable, after Allowance for Credit Loss, Current USD 330.91M 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 92.17M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 309.60M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 1.73M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 2.60M 2021-06-30 2021 Q2 10-Q 2021-07-23 0000731012-21-000068
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.32M 2016-12-31 2016 FY 10-K 2017-02-24 0000731012-17-000038
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 29.79M 2019-09-30 2019 Q3 10-Q 2019-10-25 0000731012-19-000071
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -3.36M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 334.30M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 0 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-07-24 0000731012-26-000046
us-gaap AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation USD 579,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-03 0000731012-19-000053
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.86M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 2.77M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap AdvertisingExpense Advertising Expense USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-17 0000731012-23-000024
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 8.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 113.92M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 113.92M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 9.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AllowanceForNotesAndLoansReceivableCurrent Financing Receivable, Allowance for Credit Loss, Current USD 25.02M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AllowanceForNotesAndLoansReceivableNoncurrent Financing Receivable, Allowance for Credit Loss, Noncurrent USD 2.92M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AllowanceForNotesReceivable Allowance for Notes, Loans and Financing Receivable (Deprecated 2012-01-31) USD 1.07M 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 2.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap Assets Assets USD 850.40M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AssetsCurrent Assets, Current USD 582.76M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 4.25M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 73.84M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AvailableForSaleEquitySecuritiesGrossUnrealizedGain Available-for-sale Equity Securities, Gross Unrealized Gain USD 3.40M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-03 0000731012-19-000053
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 21.35M 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 37.01M 2024-03-31 2024 Q1 10-Q 2024-04-26 0000731012-24-000065
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 25.37M 2024-03-31 2024 Q1 10-Q 2024-04-26 0000731012-24-000065
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 USD 12.22M 2024-03-31 2024 Q1 10-Q 2024-04-26 0000731012-24-000065
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 1.02M 2024-03-31 2024 Q1 10-Q 2024-04-26 0000731012-24-000065
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 69.59M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD -89,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-04-27 0000731012-18-000051
us-gaap AvailableForSaleSecuritiesGrossRealizedGains Available-for-sale Securities, Gross Realized Gains USD 226,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-10-28 0000731012-16-000165
us-gaap AvailableForSaleSecuritiesGrossRealizedLosses Available-for-sale Securities, Gross Realized Losses USD 1,000 2011-04-01 2011-06-30 2012 Q2 10-Q 2012-07-27 0001193125-12-319545
us-gaap BusinessAcquisitionContingentConsiderationAtFairValue Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) USD 3.31M 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap BusinessAcquisitionContingentConsiderationSharesIssuable Business Acquisition, Contingent Consideration, Shares Issuable (Deprecated 2013-01-31) shares 397,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap BusinessAcquisitionCostOfAcquiredEntityCashPaid Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) USD 4.61M 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap BusinessAcquisitionCostOfAcquiredEntityPurchasePrice Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) USD 13.82M 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets (Deprecated 2013-01-31) USD 5.70M 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables Business Acquisition, Purchase Price Allocation, Current Assets, Receivables (Deprecated 2013-01-31) USD 9.00M 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities Business Acquisition, Purchase Price Allocation, Current Liabilities (Deprecated 2013-01-31) USD 2.81M 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesLongTermDebt Business Acquisition, Purchase Price Allocation, Current Liabilities, Long-term Debt (Deprecated 2013-01-31) USD 4.72M 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillAmount Business Acquisition, Purchase Price Allocation, Goodwill Amount (Deprecated 2013-01-31) USD 1.94M 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-16 0000731012-24-000025
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 134.60M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 16.47M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 134.71M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 3.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 41.70M 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 3.10M 2020-03-31 2019 Q1 10-Q 2020-04-24 0000731012-20-000044
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0.86 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0.208 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-04-23 0000731012-21-000038
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 77.30M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 67.43M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap CommonStockValue Common Stock, Value, Issued USD 773,000 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 70.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price USD -13.80M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2020-03-31 2019 Q1 10-Q 2020-04-24 0000731012-20-000044
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 6.82M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 1.80M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-16 0000731012-24-000025
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 1.18B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap CostOfServices Cost of Services (Deprecated 2018-01-31) USD 469.90M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-04-27 0000731012-18-000051
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -9.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -10.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -919,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DebtAndEquitySecuritiesUnrealizedGainLoss Debt and Equity Securities, Unrealized Gain (Loss) USD 7.26M 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.017 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD -100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 100,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-04-24 0000731012-26-000031
us-gaap DeferredCompensationArrangementWithIndividualSharesIssued Deferred Compensation Arrangement with Individual, Shares Issued shares 541,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-21 0000731012-13-000034
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 59.12M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 2.48M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap DeferredCompensationPlanAssets Deferred Compensation Plan Assets USD 59.02M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 15.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 18.64M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 19.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 606,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 13.53M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 3.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 32.00M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 18.47M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxAssetsLiabilitiesNetCurrent Deferred Tax Assets, Net, Current USD 604,000 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2010-12-31 2010 FY 10-K 2011-02-18 0000950123-11-015770
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 9.82M 2016-12-31 2016 FY 10-K 2017-02-24 0000731012-17-000038
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD -677,000 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 9.87M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.69M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 4.25M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 193,000 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 5.20M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 821,000 2015-09-30 2015 Q3 10-Q 2015-10-23 0000731012-15-000072
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssets Deferred Tax Liabilities, Goodwill and Intangible Assets USD 4.42M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 2.12M 2021-12-31 2021 FY 10-K 2022-02-18 0000731012-22-000026
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 3.63M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 1.20M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 2.16M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.15 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap Depreciation Depreciation USD 9.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 11.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 64.09M 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap DueFromRelatedParties Due from Related Parties USD 750,000 2010-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 1.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 1.05 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.129 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.027 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD -100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.035 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.045 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 54.66M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 25.40M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) years 4 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 729,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions Share-based Payment Arrangement, Exercise of Option, Tax Benefit USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-17 0000731012-23-000024
us-gaap EquitySecuritiesFvNiUnrealizedGain Equity Securities, FV-NI, Unrealized Gain USD 4.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD 4.00M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-22 0000731012-21-000078
us-gaap EquitySecuritiesFvNiUnrealizedLoss Equity Securities, FV-NI, Unrealized Loss USD 600,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 27.94M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinancingReceivableAllowanceForCreditLossesRecovery Financing Receivable, Allowance for Credit Loss, Recovery USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinancingReceivableAllowanceForCreditLossesWriteOffs Financing Receivable, Allowance for Credit Loss, Writeoff USD 213,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery Financing Receivable, Allowance for Credit Loss, Writeoff, after Recovery USD 213,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinancingReceivableChangeInPresentValueExpenseReversal Financing Receivable, Change in Present Value, Expense (Reversal) USD 1.53M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-18 0000731012-22-000026
us-gaap FinancingReceivableNonaccrualInterestIncome Financing Receivable, Nonaccrual, Interest Income USD 1.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinancingReceivableOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff FinancingReceivableOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff USD 101,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinancingReceivableRecordedInvestmentPastDue Financing Receivable, Past Due USD 8.41M 2021-03-31 2021 Q1 10-Q 2021-04-23 0000731012-21-000038
us-gaap FinancingReceivableYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff FinancingReceivableYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinancingReceivableYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff FinancingReceivableYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff USD 74,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinancingReceivableYearOneOriginatedCurrentFiscalYearWriteoff FinancingReceivableYearOneOriginatedCurrentFiscalYearWriteoff USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinancingReceivableYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff FinancingReceivableYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff USD 9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinancingReceivableYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff FinancingReceivableYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 45.26M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 12.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpense Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) USD 542,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 6.88M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 941,000 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 1.61M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 1.69M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 49.90M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 16.86M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap FutureAmortizationExpenseAfterYearFive Future Amortization Expense, after Year Five (Deprecated 2012-01-31) USD 197,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap FutureAmortizationExpenseRemainderOfFiscalYear Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31) USD 1.63M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap FutureAmortizationExpenseYearFive Future Amortization Expense, Year Five (Deprecated 2012-01-31) USD 297,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap FutureAmortizationExpenseYearFour Future Amortization Expense, Year Four (Deprecated 2012-01-31) USD 569,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap FutureAmortizationExpenseYearOne Future Amortization Expense, Year One (Deprecated 2012-01-31) USD 1.85M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap FutureAmortizationExpenseYearThree Future Amortization Expense, Year Three (Deprecated 2012-01-31) USD 1.11M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap FutureAmortizationExpenseYearTwo Future Amortization Expense, Year Two (Deprecated 2012-01-31) USD 1.18M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -313,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap Goodwill Goodwill USD 90.46M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 10.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 0 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD 700,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-17 0000731012-23-000024
us-gaap GovernmentAssistanceAmount GovernmentAssistanceAmount USD 51.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap GovernmentAssistanceExpense GovernmentAssistanceExpense USD 2.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap GovernmentAssistanceLiabilityCurrent GovernmentAssistanceLiabilityCurrent USD 12.30M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap GovernmentAssistanceNonoperatingExpense GovernmentAssistanceNonoperatingExpense USD 5.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap GovernmentAssistanceNonoperatingIncome GovernmentAssistanceNonoperatingIncome USD 7.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap GovernmentAssistanceOperatingExpense GovernmentAssistanceOperatingExpense USD 34.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap ImpairedFinancingReceivableAverageRecordedInvestment Impaired Financing Receivable, Average Recorded Investment USD 27.55M 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0000731012-21-000026
us-gaap ImpairedFinancingReceivableRecordedInvestment Impaired Financing Receivable, Recorded Investment USD 24.64M 2019-12-31 2020 FY 10-K 2021-02-25 0000731012-21-000026
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-21 0000731012-13-000034
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-04-22 0000731012-22-000034
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 99.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 48.02M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-07-23 0000731012-21-000068
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -92,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncomeLossFromExtraordinaryItemsNetOfTaxPerBasicShare Income (Loss) from Extraordinary Items, Net of Tax, Per Basic Share (Deprecated 2019-01-31) USD 0 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-04-22 0000731012-16-000136
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 20.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 25.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 4.50M 2017-12-22 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 14.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 14.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap IncomeTaxReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount USD 306,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 154,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 40,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 2.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 3.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap IncreaseDecreaseInAccountsAndNotesReceivable Increase (Decrease) in Accounts and Notes Receivable USD 41.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 23.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncreaseDecreaseInDeferredCompensation Increase (Decrease) in Deferred Compensation USD 3.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable USD 572,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-16 0000731012-24-000025
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD 2.70M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-10-25 0000731012-24-000142
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -1.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 5.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncreaseDecreaseInOtherEmployeeRelatedLiabilities Increase (Decrease) in Other Employee-Related Liabilities USD 23.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net USD -814,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-04-24 0000731012-26-000031
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 8.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -4.66M 2011-01-01 2011-03-31 2011 Q1 10-Q 2011-04-25 0000950123-11-038735
us-gaap IncreaseDecreaseInPrepaidTaxes Increase (Decrease) in Prepaid Taxes USD 915,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-04-22 0000731012-16-000136
us-gaap IncreaseDecreaseInSelfInsuranceReserve Increase (Decrease) in Self Insurance Reserve USD -13.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap IncreaseDecreaseInWorkersCompensationLiabilities Increase (Decrease) in Workers' Compensation Liabilities USD -8.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap IncrementalCommonSharesAttributableToContingentlyIssuableShares Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares shares 228,000 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 650,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-04-22 0000731012-16-000136
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 48.68M 2022-12-31 2022 FY 10-K 2023-02-17 0000731012-23-000024
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 15.95M 2022-12-31 2022 FY 10-K 2023-02-17 0000731012-23-000024
us-gaap InterestExpense Interest Expense USD 3.46M 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 1.36M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-23 0000731012-18-000032
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap InventoryNet Inventory, Net USD 15.53M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 67,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-07-24 0000731012-26-000046
us-gaap InvestmentIncomeNet Investment Income, Net USD 10.68M 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 476,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-04-27 0000731012-18-000051
us-gaap LeaseCost Lease, Cost USD 9.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 21.01M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 4.61M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 6.32M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.24M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.24M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.63M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 4.46M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.76M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.97M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 40.42M 2012-09-30 2012 Q3 10-Q 2012-10-22 0001193125-12-430162
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 850.40M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LiabilitiesCurrent Liabilities, Current USD 206.42M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LineOfCredit Long-term Line of Credit USD 0 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 0 2014-03-31 2014 Q1 10-Q 2014-04-24 0000731012-14-000047
us-gaap LineOfCreditFacilityInterestRateAtPeriodEnd Line of Credit Facility, Interest Rate at Period End pure 0.073 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 300.00M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 268.00M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 0 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap LitigationReserve Estimated Litigation Liability USD 6.00M 2021-06-30 2021 Q2 10-Q 2021-07-23 0000731012-21-000068
us-gaap LossContingencyEstimateOfPossibleLoss Loss Contingency, Estimate of Possible Loss USD 10.00M 2021-03-31 2021 Q1 10-Q 2021-04-23 0000731012-21-000038
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 1.13M 2015-06-30 2015 Q2 10-Q 2015-07-22 0000731012-15-000060
us-gaap MarketableSecurities Marketable Securities USD 69.50M 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 34.22M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 1.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -59.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -32.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 95.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 73.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 18.63M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-04-22 0000731012-16-000136
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 18.63M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-04-22 0000731012-16-000136
us-gaap NotesAndLoansReceivableGrossCurrent Financing Receivable, before Allowance for Credit Loss, Current USD 61.80M 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap NotesAndLoansReceivableGrossNoncurrent Financing Receivable, before Allowance for Credit Loss, Noncurrent USD 43.94M 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 24.50M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap NotesAndLoansReceivableNetNoncurrent Financing Receivable, after Allowance for Credit Loss, Noncurrent USD 42.35M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap NotesReceivableNet Financing Receivable, after Allowance for Credit Loss USD 70.40M 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap NumberOfStatesInWhichEntityOperates Number of States in which Entity Operates state 48 2016-09-30 2016 Q3 10-Q 2016-10-28 0000731012-16-000165
us-gaap OciBeforeReclassificationsNetOfTaxAttributableToParent OCI, before Reclassifications, Net of Tax, Attributable to Parent USD -3.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 423.56M 2019-10-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap OperatingLeaseCost Operating Lease, Cost USD 5.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 4.70M 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 18.04M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 6.61M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 11.43M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OperatingLeasePayments Operating Lease, Payments USD 4.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 33.22M 2021-12-31 2021 FY 10-K 2022-02-18 0000731012-22-000026
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 5.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 9.13M 2018-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 3.20M 2018-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 677,000 2018-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 677,000 2018-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.10M 2018-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.80M 2018-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 677,000 2018-12-31 2018 FY 10-K 2019-03-18 0000731012-19-000040
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 4.00M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0000731012-21-000026
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.065 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 36.51M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherAssetsCurrent Other Assets, Current USD 14.03M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 9.54M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -2.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax USD 600,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-10-27 0000731012-17-000102
us-gaap OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax USD 535,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -2.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent USD -800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -2.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 118,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-10-22 0001193125-12-430162
us-gaap OtherInventory Other Inventory, Gross USD 15.89M 2026-03-31 2026 Q1 10-Q 2026-04-24 0000731012-26-000031
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.08M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 814,000 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 6.22M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherSundryLiabilitiesCurrent Other Sundry Liabilities, Current USD 7.24M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 4.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 56.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 61.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap PaymentsOfDividendsCommonStock Payments of Ordinary Dividends, Common Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 1.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-04-24 0000731012-26-000031
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 22.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 4.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 21.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 5.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 28.83M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 20.93M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap PrepaidInsurance Prepaid Insurance USD 6.10M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap PrepaidTaxes Prepaid Taxes USD 915,000 2016-03-31 2016 Q1 10-Q 2016-04-22 0000731012-16-000136
us-gaap ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates Proceeds from Divestiture of Interest in Subsidiaries and Affiliates USD 1.10M 2009-01-01 2009-03-01 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap ProceedsFromRepaymentsOfShortTermDebt Proceeds from (Repayments of) Short-term Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 21.26M 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 2.40M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-04-27 0000731012-18-000051
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 21.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 160,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ProceedsFromSaleOfTreasuryStock Proceeds from Sale of Treasury Stock USD 66,000 2011-01-01 2011-06-30 2011 Q2 10-Q 2011-07-22 0001193125-11-194717
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-25 0000731012-25-000100
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 58.76M 2019-09-30 2019 Q3 10-Q 2019-10-25 0000731012-19-000071
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 29.01M 2020-03-31 2019 Q1 10-Q 2020-04-24 0000731012-20-000044
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 147,000 2015-06-30 2015 Q2 10-Q 2015-07-22 0000731012-15-000060
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ProvisionForLoanLossesExpensed Financing Receivable, Credit Loss, Expense (Reversal) USD 450,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 226,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-10-28 0000731012-16-000165
us-gaap ReceivableWithImputedInterestEffectiveYieldInterestRate Receivable with Imputed Interest, Effective Yield (Interest Rate) pure 0.071 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ReceivableWithImputedInterestFaceAmount Receivable with Imputed Interest, Face Amount USD 58.90M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ReceivableWithImputedInterestNetAmount Receivable with Imputed Interest, Net Amount USD 56.20M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD 17,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent USD -118,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 120,000 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap RelatedPartyTransactionRevenuesFromTransactionsWithRelatedParty Related Party Transaction, Revenues from Transactions with Related Party (Deprecated 2012-01-31) USD 4.14M 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap RepaymentsOfAssumedDebt Repayments of Assumed Debt USD 4.72M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-18 0000731012-22-000026
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 115,000 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 115,000 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap RestrictedInvestmentsCurrent Restricted Investments, Current USD 35.37M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 357.30M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 1.41B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 901.18M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-07-24 0000731012-20-000066
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 4.14M 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-21 0000731012-13-000034
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 13.70M 2023-12-31 2023 FY 10-K 2024-02-16 0000731012-24-000025
us-gaap RevenueRemainingPerformanceObligationPercentage Revenue, Remaining Performance Obligation, Percentage pure 1 2023-12-31 2023 FY 10-K 2024-02-16 0000731012-24-000025
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 12.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 499.41M 2017-10-01 2017-12-31 2017 FY 10-K 2018-02-23 0000731012-18-000032
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 501.81M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-04-27 0000731012-18-000051
us-gaap SegmentExpenditureAdditionToLongLivedAssets SegmentExpenditureAdditionToLongLivedAssets USD 5.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap SelfInsuranceReserveCurrent Self Insurance Reserve, Current USD 21.35M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap SelfInsuranceReserveNoncurrent Self Insurance Reserve, Noncurrent USD 64.37M 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 143.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 8.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 10.39 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.421 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.045 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 2.20M 2019-09-30 2019 Q3 10-Q 2019-10-25 0000731012-19-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 300,000 2020-03-31 2019 Q1 10-Q 2020-04-24 0000731012-20-000044
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 2.71M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.57M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 29.87 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 4.47 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) USD 10.08 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 301,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 93,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-10-27 0000731012-17-000102
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 33.66 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-10-27 0000731012-17-000102
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 561,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) USD 17.5 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 6.08 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 1.46M 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 79,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 6.7 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 6.65 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 7.06M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.11M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 25.39 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) Y 5 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) USD 1.87M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-10-22 0001193125-12-430162
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 486,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 5.17 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-19 0000731012-16-000120
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 16.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 34.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 8.9 2012-09-30 2012 Q3 10-Q 2012-10-22 0001193125-12-430162
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 1.04M 2012-12-31 2012 FY 10-K 2013-02-21 0000731012-13-000034
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 2.63M 2012-12-31 2012 FY 10-K 2013-02-21 0000731012-13-000034
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 6.5 2012-03-31 2012 Q1 10-Q 2012-04-27 0001193125-12-191127
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 613,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap ShortTermLeasePayments Short-term Lease Payments USD 830,000 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 531.45M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap StockholdersEquityNoteStockSplitConversionRatio Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) pure 1.5 2010-10-11 2010-10-12 2012 FY 10-K 2013-02-21 0000731012-13-000034
us-gaap StockholdersEquityOther Stockholders' Equity, Other USD -3,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 396,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-10-22 0001193125-12-430162
us-gaap StockIssuedDuringPeriodSharesDividendReinvestmentPlan Stock Issued During Period, Shares, Dividend Reinvestment Plan shares 4,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-10-22 0001193125-12-430162
us-gaap StockIssuedDuringPeriodSharesEmployeeBenefitPlan Stock Issued During Period, Shares, Employee Benefit Plan shares 10,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-10-22 0001193125-12-430162
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 70,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-10-22 0001193125-12-430162
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 74,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap StockIssuedDuringPeriodSharesStockSplits Stock Issued During Period, Shares, Stock Splits shares 22.00M 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-21 0000731012-13-000034
us-gaap StockIssuedDuringPeriodSharesTreasuryStockReissued Stock Issued During Period, Shares, Treasury Stock Reissued shares 6,000 2010-01-01 2010-09-30 2010 Q3 10-Q 2010-10-22 0000950123-10-095293
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 6.94M 2017-01-01 2017-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap StockIssuedDuringPeriodValueDividendReinvestmentPlan Stock Issued During Period, Value, Dividend Reinvestment Plan USD 106,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 470,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-16 0000731012-24-000025
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.68M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 75,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0000731012-25-000032
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 41,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap StockIssuedDuringPeriodValueTreasuryStockReissued Stock Issued During Period, Value, Treasury Stock Reissued USD 316,000 2010-01-01 2010-09-30 2010 Q3 10-Q 2010-10-22 0000950123-10-095293
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 444,000 2008-01-01 2008-12-31 2010 FY 10-K 2011-02-18 0000950123-11-015770
us-gaap StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Number of Shares Authorized to be Repurchased shares 7.50M 2023-02-14 2023 FY 10-K 2024-02-16 0000731012-24-000025
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap TradingSecuritiesUnrealizedHoldingGainLoss Trading Securities, Change in Unrealized Holding Gain (Loss) USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-21 0000731012-14-000034
us-gaap TradingSecuritiesUnrealizedHoldingLoss Trading Securities, Unrealized Holding Loss USD 82,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-21 0000731012-13-000034
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 9.87M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 157.56M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap TreasuryStockShares Treasury Stock, Shares shares 2.07M 2022-09-30 2022 Q3 10-Q 2022-10-21 0000731012-22-000084
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 4.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap TreasuryStockValue Treasury Stock, Value USD 27.92M 2022-09-30 2022 Q3 10-Q 2022-10-21 0000731012-22-000084
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 12.75M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap UnrealizedGainLossOnSecurities Unrealized Gain (Loss) on Securities USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-19 0000731012-15-000033
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-06-30 2025 Q2 10-Q 2025-07-25 0000731012-25-000100
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-16 0000731012-24-000025
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 400,000 2026-03-31 2026 Q1 10-Q 2026-04-24 0000731012-26-000031
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 147.01M 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 83.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap ValuationAllowancesAndReservesChargedToOtherAccounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-17 0000731012-23-000024
us-gaap ValuationAllowancesAndReservesDeductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction USD 36.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0000731012-26-000009
us-gaap VariableLeaseCost Variable Lease, Cost USD 3.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap VariableLeasePayment Variable Lease, Payment USD 591,000 2019-01-01 2019-12-31 2018 FY 10-K 2020-02-21 0000731012-20-000033
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 1.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 70.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 68.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059
us-gaap WorkersCompensationDiscountAmount Workers' Compensation Discount, Amount USD 1.10M 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-075632
us-gaap WorkersCompensationDiscountPercent Workers' Compensation Discount, Percent pure 0.08 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-21 0000731012-14-000034
us-gaap WorkersCompensationLiabilityCurrent Workers' Compensation Liability, Current USD 23.08M 2019-09-30 2019 Q3 10-Q 2019-10-25 0000731012-19-000071
us-gaap WorkersCompensationLiabilityNoncurrent Workers' Compensation Liability, Noncurrent USD 41.16M 2026-09-30 2026 Q3 10-Q 2026-10-23 0000731012-26-000059

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →